Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation

Anesthesiology

Volumn 119, Issue 1, 2013, Pages 36-42

  Pongrácz, Adrienn ^a   Szatmári, Szilárd ^a   Nemes, Réka ^a   Fülesdi, Béla ^a   Tassonyi, Edömér ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; FENTANYL; MIDAZOLAM; NEOSTIGMINE; PROPOFOL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX;

ADULT; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENERAL ANESTHESIA; HUMAN; INCIDENCE; MALE; MUSCLE EXCITATION; MUSCLE TWITCH; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANDROSTANOLS; ANESTHESIA, GENERAL; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION; ENDPOINT DETERMINATION; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PREANESTHETIC MEDICATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883210034     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318297ce95     Document Type: Article

References (23)

1. Plaud B, Debaene B, Donati F, Marty J: Residual paralysis after emergence from anesthesia. Anest hesiology 2010; 112:1013-22
2. Srivastava A, Hunter JM: Reversal of neuromuscular block. Br J Anaesth 2009; 103:115-29
3. Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA: Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: A multicenter, randomized, controlled trial. Anesth Analg 2010; 110:64-73
4. Jones RK, Caldwell JE, Brull SJ, Soto RG: Reversal of profound rocuronium-induced blockade with sugammadex: A randomized comparison with neostigmine. Anest hesiology 2008; 109:816-24
5. McIntyre JA, Castaner J: Sugammadex sodium. Drugs Fut 2005; 30:780-4
6. de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M: Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: A multicenter, dose-finding and safety study. Anest hesiology 2007; 107:239-44
7. Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, Viby-Mogensen J: Reversal of rocuroniuminduced neuromuscular block by the selective relaxant binding agent sugammadex: A dose-finding and safety study. Anest hesiology 2006; 104:667-74
8. Kopman AF: Neostigmine versus sugammadex: Which, when, and how much? Anest hesiology 2010; 113:1010-1
9. G ijsenbergh F, Ramael S, Houwing N, van Iersel T: First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anest hesiology 2005; 103:695-703
10. Schulz KF, Grimes DA: Generation of allocation sequences in randomised trials: Chance, not choice. Lancet 2002; 359:515-9
11. Fuchs-Buder T, Claudius C, Skofgaard LT, Eriksson LI , Mirakhur RK, Viby-Mogensen J: Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II : The Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789-808
12. Claudius C, Skovgaard LT, Viby-Mogensen J: Is the performance of acceleromyography improved with preload and normalization? A comparison with mechanomyography. Anest hesiology 2009; 110:1261-70
13. Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T: Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic trainof-four ratio of 0.9. Anest hesiology 2004; 100:1119-24
14. Schaller SJ, Fink H, Ulm K, Blobner M: Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anest hesiology 2010; 113:1054-60
15. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I: Effective reversal of moderate rocuronium-or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anest hesiology 2007; 106:283-8
16. Sacan O, White PF, Tufanogullari B, Klein K: Sugammadex reversal of rocuronium-induced neuromuscular blockade: A comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Anesth Analg 2007; 104:569-74
17. Blobner M, Eriksson LI , Scholz J, Motsch J, Della Rocca G, Prins ME: Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: Results of a randomised, controlled trial. Eur J Anaesthesiol 2010; 27:874-81
18. Kirkegaard H, Heier T, Caldwell JE: Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anest hesiology 2002; 96:45-50
19. Reid JE, Breslin DS, Mirakhur RK, Hayes AH: Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol. Can J Anaesth 2001; 48:351-5
20. Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V, Kalmar AF, Prins ME: Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104:563-8
21. Kopman AF: Tactile evaluation of train-of-four count as an indicator of reliability of antagonism of vecuronium-or atracurium-induced neuromuscular blockade. Anest hesiology 1991; 75:588-93
22. Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Vender JS, Gray J, Landry E, Gupta DK: Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anest hesiology 2011; 115:946-54
23. Arbous MS, Meursing AE, van Kleef JW, de Lange JJ, Spoormans HH , Touw P, Werner FM, Grobbee DE: Impact of anesthesia management characteristics on severe morbidity and mortality. Anest hesiology 2005; 102:257-68; quiz 491-2